VA - (3 Mos. Post-Separation) | |||||||
Code | Rating | Condition | Code | Rating | Exam | ||
Asthma, Moderate Persistent | 10% | 6602 | Asthma | 6602 | 30% | 20020108 | |
Other x 3 | 20020108 | ||||||
Combined: 30% |
VASRD CODE | RATING | ||
Asthma Condition | 6602 | 30% | |
30% |
AF | PDBR | CY2013 | PD-2013-01963
The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of the VASRD standards to the unfitting medical condition at the time of separation. The Board next considered that at the time of separation, although the CI’s asthma was relatively well controlled,treatment notes in the STR, the MEB and C&P exams consistently documented use of the anti-inflammatory inhaler and oral bronchodilator medications, with...
AF | PDBR | CY2013 | PD-2013-02765
The requested sleep apnea, anxiety, hypertension and rhinitis conditions were not identified by the PEB, and therefore not within the DoDI 6040.44 defined purview of the Board.Any conditions or contention not requested in this application, or otherwise outside the Board’s defined scope of review, remain eligible for future consideration by the Board for Correction of Military Records. Asthma Condition . The PEB TDRL exit rating was 10%,with the disability description stating: “not...
AF | PDBR | CY2013 | PD-2013-01954
SEPARATION DATE: 20050331 The Board found the CI met the higher 30% evaluation due to “ inhalational anti-inflammatory medication” (Advair)use at the time of separation as specified under code 6602.After due deliberation, considering all of the evidence and mindful of VASRD §4.3 (reasonable doubt), the Board recommends a disability rating of 30% for the asthma condition. Under the authority of Title 10, United States Code, section 1554(a), I approve the enclosed recommendation of the...
AF | PDBR | CY2013 | PD2013 01411
RECORD OF PROCEEDINGSPHYSICAL DISABILITY BOARD OF REVIEWNAME: XXXXXXXXXXXXXXXXXX CASE: PD1301411 BRANCH OF SERVICE: Army BOARD DATE: 20140122 At that time a diagnosis of mild persistent asthma aggravated by exposure to petroleum products was rendered.At the separation exam on 17 November 2003, the CI reported using inhalers “when needed for asthma.”Review of the STR showed one note in evidence documenting the use of an oral steroid for asthma (September 2003).At a clinic visit for...
AF | PDBR | CY2013 | PD-2013-02334
The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of theVASRD standards to the unfitting medical condition at the time of separation. The §4.97 criteria for a 30% rating are “FEV-1 of 56- to 70-percent predicted, or; FEV-1/FVC of 56 to 70 percent, or; daily inhalational or oral bronchodilator therapy, or; inhalational anti-inflammatory medication;” and, those for 10% are “FEV-1 of 71- to 80-percent...
AF | PDBR | CY2013 | PD-2013-01552
The service treatment record (STR) initially reflected that the CI wasbeing worked-up for a respiratory condition noting the first of many spirometry/pulmonary function tests (PFTs) dated 28 August 2002. The CI was never placed on oral corticosteroids; therefore, Board members deliberated if the CI’s condition supported the 30% criteria level.Clearly, the final pulmonology report noted no use of medication for the previous “several months.”Additionally, the post-separation VA examination...
AF | PDBR | CY2012 | PD2012-00289
The narrative summary (NARSUM), service treatment records (STR), and prior to separation VA C&P examination all indicate that the CI required and used daily inhalational bronchodilator and oral medications which would support a 30% rating IAW VASRD code 6602 (“daily inhalational or oral bronchodilator therapy or inhalational anti-inflammatory medication”) and VASRD §4.97. RECOMMENDATION : The Board recommends that the CI’s prior determination be modified as follows; and, that the discharge...
AF | PDBR | CY2011 | PD2011-00244
Asthma Condition . FEV1 (% Predicted)113%(VA 70%) 75%FEV1/FVC98.9%67%Medsalbuterol inhaler (as needed, 2-3 x/day); begin budesonide inhaler;budesonide inhaler twice daily, albuterol inhaler (as needed) - 2-3 times per dayfluticasone & salmeterol twice daily, albuterol inhaler … as needed, uses 2x/day if forgets other inhalersSpirometry NotesPositive methacholine challenge; no significant change after bronchodilatorreturned to normal after bronchodilator§4.97 Rating30%30%30%The service...
AF | PDBR | CY2011 | PD 2011 01084
TDRL Rating Chart Final Service IPEB Dated 20021001 VA All Effective Date 20030911 Condition Code Rating Condition Code Rating Exam On TDRL 20010813 TDRL Sep. Asthma 6602 30% 0% Asthma 6602 30%* 20031023 .No Additional MEB/PEB Entries. The PEB rated the condition as 6602 asthma, bronchial and assigned a 30% disability stating the asthma condition was only moderately controlled on multiple medications, including daily inhaled anti-inflammatory aerosols. RECOMMENDATION: The Board...
AF | PDBR | CY2014 | PD 2014 00205
SEPARATION DATE: 20071029 The narrative summary (NARSUM) performed on 13 June 2007 (4 months prior to separation), the CI reported “consistently feels SOB with exertion.” His physical examination (PE) was normal and the corresponding pulmonary function test (PFT)was 96% and 93% predicted for FEV1 and FVC respectively. Additionally, secondary to the inconsistent documentation, members also considered the probative value between the MEB and VA examination and concluded that the MEB...